Medivir AB (publ) (STO: MVIR)

Medivir AB Ratios and Metrics

Market cap in millions SEK. Fiscal year is January - December.

Fiscal Year	Current	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Jan 28, 2025	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Market Capitalization	320	159	552	624	201	301
Market Cap Growth	-16.85%	-71.16%	-11.61%	209.74%	-33.10%	-48.23%
Enterprise Value	237	110	424	411	119	143
Last Close Price	2.85	2.85	8.11	9.18	5.58	8.34
PS Ratio	41.99	20.85	125.15	19.27	9.86	34.52
PB Ratio	2.25	0.73	2.86	2.22	1.42	1.63
P/TBV Ratio	7.20	0.73	2.86	2.22	1.42	1.63
EV/Sales Ratio	33.65	14.40	96.27	12.69	5.81	16.35
EV/FCF Ratio	-2.39	-	-	-	-	-
Debt / Equity Ratio	0.07	0.06	0.08	0.05	0.12	0.24
Asset Turnover	0.04	0.03	0.02	0.12	0.08	0.02
Quick Ratio	1.84	3.03	4.37	5.40	2.24	2.75
Current Ratio	1.84	3.05	4.39	5.42	2.28	2.78
Return on Equity (ROE)	-87.81%	-43.50%	-37.46%	-29.84%	-26.12%	-50.17%
Return on Assets (ROA)	-40.02%	-22.21%	-19.43%	-15.27%	-15.68%	-22.55%
Return on Capital (ROIC)	-52.90%	-26.36%	-22.00%	-17.75%	-19.66%	-29.99%
Earnings Yield	-36.57%	-56.14%	-16.09%	-10.11%	-21.15%	-40.99%
FCF Yield	-30.99%	-37.50%	-18.53%	-7.81%	-30.14%	-49.70%
Buyback Yield / Dilution	-84.59%	-8.44%	-5.53%	-117.45%	-	-1.38%
Total Shareholder Return	-84.59%	-8.44%	-5.53%	-117.45%	-	-1.38%

Source: S&P Capital IQ. Standard template. Financial Sources.